Authors

David H. Aggen, MD, PhD

Attending

Genitourinary Oncology Service

Memorial Sloan Kettering Cancer Center

New York, New York

Renal Cell Cancer

Ivan Aksentijevich, MD

Virginia Cancer Specialists

Specialist in Medical Oncology and Hematology

Alexandria, Virginia

Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia

Srivandana Akshintala, MBBS, MPH

Assistant Research Physician

Pediatric Oncology Branch

Center for Cancer Research

National Cancer Institute

Bethesda, Maryland

Sarcomas

Tamarah A. Al-Dawoodi, MD

University of Nevada, Las Vegas School of Medicine

University Medical Center

Las Vegas, Nevada

Mesothelioma

Philippe Armand, MD, PhD

Chief, Division of Lymphoma

Harold and Virginia Lash Endowed Chair in Lymphoma Research

Associate Professor of Medicine, Harvard Medical School

Non-Hodgkin Lymphoma

Mohamed M. Azab, MD

University of Nevada, Las Vegas School of Medicine

University Medical Center

Las Vegas, Nevada

Mesothelioma

Carmen Joseph Allegra, MD

Professor and Chief Hematology and Oncology

Department of Medicine

University of Florida Health

Gainesville, Florida

Colorectal Cancer

Jennifer E. Amengual, MD

Herbert Irving Assistant Professor of Medicine

Division of Hematology and Oncology

Herbert Irving Comprehensive Cancer Center

Columbia University Irving Medical Center

New York, New York

Non-Hodgkin Lymphoma

Kenneth C. Anderson, MD

Professor of Medicine, Department of Medicine,

Harvard Medical School

Physician, Oncology, Brigham and Women’s Hospital

Medical Director, Kraft Family Blood Center,

Dana-Farber Cancer Institute

Boston, Massachusetts

Multiple Myeloma

Andrea B. Apolo, MD

Investigator and Lasker Scholar

Chief, Bladder Cancer Section

Genitourinary Malignancies Branch

Center for Cancer Research, National Cancer Institute

National Institutes of Health

Bethesda, Maryland

Bladder Cancer

Megan Askew, MD

Division of Hematology

Department of Pediatrics

Columbia University Medical Center

Idiopathic Thrombocytopenic Purpura

Dean Bajorin, MD

Member and Professor of Medicine

Genitourinary Oncology Service

Memorial Sloan-Kettering Cancer Center

New York, New York

Bladder Cancer

James C. Barton, MD

Medical Director, Southern Iron Disorders Center

Clinical Professor of Medicine

University of Alabama at Birmingham

Birmingham, Alabama

Hemochromatosis

Susan E. Bates, MD

Professor of Medicine

Division of Hematology and Oncology

Department of Medicine

Columbia University

New York, New York

Pancreatic Cancer, Tissue-Agnostic Therapies

Kenneth A. Bauer, MD

Professor of Medicine, Harvard Medical School

Director, Thrombosis Clinical Research,

Beth Israel Deaconess Medical Center

Boston, Massachusetts

The Hypercoagulable State

Sigbjørn Berentsen, MD, PhD

Consultant Hematologist and Senior Researcher

Department of Research and Innovation

Helse Fonna HF, Haugesund Hospital

Haugesund, Norway

Autoimmune Hemolytic Anemia

Ann Berger, MSN, MD

Chief, Pain and Palliative Care Service

National Institutes of Health Clinical Center

Bethesda, Maryland

Cancer Pain: Assessment and Management

Giada Bianchi, MD

Department of Medical Oncology, Instructor in Medicine

Dana Farber Cancer Institute

Harvard Medical School

Boston, Massachusetts

Multiple Myeloma

Michael R. Bishop, MD

Professor of Medicine

Director, Hematopoietic Stem Cell Transplantation Program

The University of Chicago Medicine

Chicago, Illinois

Complications and Follow-Up After Hematopoietic Cell Transplantation

Jean-Yves Blay, MD

Professor of Medicine in Medical Oncology

Head of the Medical Oncology Department

Centre Leon Berard of the Université Claude Bernard

Scientific Director, Canceropole Lyon Rhône Alpes

Lyon, France

Sarcomas

Leslie Boyd, MD

Assistant Professor of Gynecology

Perlmutter Cancer Center

NYU Langone Medical Center

New York, New York

Vaginal Cancer

Michael M. Boyiadzis, MD, MHSc

Professor of Medicine and Clinical and Translational Science

Department of Medicine, Division of Hematology-Oncology

University of Pittsburgh School of Medicine

UPMC Hillman Cancer Center

Pittsburgh, Pennsylvania

Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia;

Myelodysplastic Syndromes

Diana Brewer, PA

Physician Assistant

Center for Hematologic Malignancies

Instructor of Medicine, School of Medicine

Oregon Health & Science University

Portland, Oregon

Chronic Myeloid Leukemia

Kathleen A. Calzone, PhD, RN, APNG, FAAN

Senior Nurse Specialist, Research

National Cancer Institute

Center for Cancer Research, Genetics Branch

Bethesda, Maryland

Cancer Screening; Genetics of Common Inherited Cancer Syndromes

Lisa Cordes, PharmD, BCACP, BCOP

Oncology Clinical Pharmacy Specialist & Educator

National Institutes of Health

Bethesda, Maryland

Indications for Bone-Modifying Agents in Hematology-Oncology

Mary Czech, MD

National Institutes of Health

Bethesda, Maryland

Fever and Neutropenia

William L. Dahut, MD

Scientific Director for Clinical Research

Genitourinary Malignancies Branch

Center for Cancer Research

National Cancer Institute

National Institutes of Health

Bethesda, Maryland

Prostate Cancer

Nancy E. Davidson, MD

Senior Vice President, Director and Professor

Clinical Research Division, Fred Hutch

Raisbeck Endowed Chair for Collaborative Research

Fred Hutch

President and Executive Director

Seattle Cancer Care Alliance

Seattle, Washington

Breast Cancer

Michael W.N. Deininger, MD, PhD

M.M. Wintrobe Professor of Medicine

Chief, Division of Hematology and Hematologic Malignancies

Senior Director for Transdisciplinary Research

University of Utah

Huntsman Cancer Institute

Salt Lake City, Utah

Chronic Myeloid Leukemia

Volker Diehl, MD

Emeritus Professor of Medicine, Hematology, Oncology

University of Cologne

Cologne, Germany

Hodgkin Lymphoma

David L. Diuguid, MD

Professor of Medicine

Department of Medicine, Division of Hematology and Oncology

Columbia University

New York, New York

Heparin-Induced Thrombocytopenia

Don S. Dizon, MD, FACP, FASCO

Professor of Medicine, Brown University

Director, Women’s Cancers and Hematology-Oncology Outpatient Clinics, Lifespan Cancer Institute

Director, Medical Oncology and the Oncology Sexual Health Program

Rhode Island Hospital

Providence, Rhode Island

Endometrial Cancer

Brian J. Druker, MD

Professor of Medicine, Division of Hematology and Medical Oncology

Director, Oregon Health & Science University Knight Cancer Institute

JELD-WEN Chair of Leukemia Research

Oregon Health & Science University

Portland, Oregon

Chronic Myeloid Leukemia

Jennifer M. Duff, MD

Assistant Chief of Medical Service

Associate Professor of Hematology and Oncology

University of Florida Health

Gainesville, Florida

Colorectal Cancer

Sara Ekeblad, MD, PhD

Uppsala University Hospital

Stockholm, Sweden

Neuroendocrine Tumors

Darren R. Feldman, MD

Member, Department of Medicine

Memorial Sloan Kettering Cancer Center, and

Associate Professor in Medicine, Weill Cornell Medical College

New York, New York

Testicular Cancer

Jonas W. Feilchenfeldt, MD

Attending Physician

FMH Internal Medicine and Medical Oncology

Department of Medical Oncology

Hôpital du Valais

Sion, Switzerland

Gastric Cancer

Enriqueta Felip, MD, PhD

Vall d’Hebron Institute of Oncology

Vall d’Hebron University Hospital

Barcelona, Spain

Lung Cancer

Howard A. Fine, MD

Director of the Brain Tumor Center

NewYork-Presbyterian Weill Cornell Medical Center

New York, New York

Central Nervous System Cancers

Tito Fojo, MD, PhD

Professor of Medicine

Department of Medicine, Division of Hematology-Oncology

Columbia University

Herbert Irving Comprehensive Cancer Center

New York, New York

Adrenocortical Cancer; Guidelines for Chemotherapy Dosage Adjustment; Indications for Growth Factors in Hematology-Oncology; Oncologic Emergencies; Pheochromocytoma; Tissue-Agnostic Therapies; Indications for Bone-Modifying Agents in Hematology-Oncology

Michael Fuchs, MD

Head of the Trial Coordination Center German Hodgkin Study Group

Department of Internal Medicine

University Hospital of Cologne

Cologne, Germany

Hodgkin Lymphoma

Naseema Gangat, MD

Associate Professor of Medicine

Division of Hematology

Mayo Clinic

Rochester, Minnesota

Myeloproliferative Neoplasms

Juan C. Gea-Banacloche, MD

National Institute of Allergy and Infectious Diseases (NIAID)

Bethesda, Maryland

Fever and Neutropenia; Complications and Follow-Up After Hematopoietic

Cell Transplantation

Timothy J. George, PharmD, BCOP

UPMC Shadyside Hospital

Pittsburgh, Pennsylvania

Guidelines for Chemotherapy Dosage Adjustment

Irene M. Ghobrial, MD

Professor of Medicine

Dana-Farber Cancer Institute

Harvard Medical School

Boston, Massachusetts

Multiple Myeloma

Giuseppe Giaccone, MD, PhD

Associate Director for Clinical Research

Sandra and Edward Meyer Cancer Center

Weill-Cornell Medicine

New York, New York

Thymic Malignancies

Mark T. Gladwin, MD

Jack D. Myers Distinguished Professor and Chair

Chairman of the Department of Medicine

UPMC and the University of Pittsburgh School of Medicine

Pittsburgh, Pennsylvania

Sickle Cell Disease: Acute Complications

F. Anthony Greco, MD

Co-Founder, Sarah Cannon Research Institute

Investigator

Tennessee Oncology

Nashville, Tennessee

Carcinoma of Unknown Primary

Tim Greten, MD, PhD

Deputy Branch Chief & Senior Investigator

Thoracic and GI Malignancies Branch

Co-Director, NCI CCR Liver Cancer Program

National Cancer Institute

National Institutes of Health

Bethesda, Maryland

Biliary: Gallbladder Cancer and Cholangiocarcinoma; Hepatocellular Carcinoma

Christine D. Hudak, MD

Hospice & Palliative Medicine for OhioHealth

Columbus, Ohio

Hospice Care and End-of-Life Issues

Thomas E. Hughes, PharmD, BCOP

Oncology Clinical Pharmacy Specialist

Pharmacy Department

National Institutes of Health

Bethesda, Maryland

Prophylaxis and Treatment of Chemotherapy-Induced Nausea and Vomiting

Irfan Jawed, MD

Medical Oncologist

Memorial Hermann Southeast Hospital

Pasadena, Texas

Anal Cancer

Ramasubramanian Kalpatthi, MD

Associate Professor of Pediatrics

UPMC Children’s Hospital of Pittsburgh

Pittsburgh, Pennsylvania

Sickle Cell Disease: Acute Complications

Fatima Karzai, MD

Associate Research Physician

Genitourinary Malignancies Branch

National Cancer Institute

National Institutes of Health

Bethesda, Maryland

Prostate Cancer

Lyndon Kim, MD

Division of Neuro-Oncology

Department of Neurological Surgery

Department of Medical Oncology

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania

Central Nervous System Cancers

Sunnie Kim, MD

Assistant Professor

University of Colorado Cancer Center

Aurora, Colorado

Esophageal Cancer

Chul Kim, MD, MPH

Assistant Professor

Medstar Georgetown University Hospital

Washington DC

Thymic Malignancies

John M. Kirkwood, MD

Distinguished Service Professor of Medicine

Usher Professor of Medicine, Dermatology and Translational Science

Co-Director, Melanoma and Skin Cancer Program

University of Pittsburgh School of Medicine

UPMC Hillman Cancer Center

Pittsburgh, Pennsylvania

Melanoma

Joseph E. Kiss, MD

Professor of Medicine

Department of Medicine

Division of Hematology-Oncology

Medical Director, Hemapheresis and Blood Services

University of Pittsburgh School of Medicine

Pittsburgh, Pennsylvania

Transfusion Therapy

Satyajit Kosuri, MD

Clinical Director - Hematopoietic Cellular Therapy Program

Section of Hematology and Oncology

University of Chicago Medical Center

Chicago, Illinois

Complications and Follow-Up After Hematopoietic Cell Transplantation

Livia Lamartina, MD, PhD

Department of Nuclear Medicine and Endocrine Oncology

Gustave Roussy, Université Paris-Saclay

Villejuif, France

Thyroid Cancer

John R. Lurain, MD

Marcia Stenn Professor of Gynecologic Oncology

John I. Brewer Trophoblastic Disease Center

Northwestern University, Feinberg School of Medicine

Chicago, Illinois

Gestational Trophoblastic Neoplasia

Kathryn Lurain, MD, MPH

Center for Cancer Research

National Cancer Institute

Bethesda, Maryland

HIV-Related Malignancies

Mark R. Litzow, MD

Professor of Medicine

Mayo Clinic

Rochester, Minnesota

Acute Lymphoblastic Leukemia

Pier M. Mannucci, MD

Professor

Scientific Direction

IRCCS Ca’ Granda Maggiore Policlinico Hospital Foundation

Milano, Italy

von Willebrand Disease

Gerard P. Mascara, PharmD, BCOP

Adjunct Assistant Professor of Pharmacy and Therapeutics

University of Pittsburgh School of Pharmacy

VA Pittsburgh Healthcare System

Pittsburgh, Pennsylvania

Content represents Dr. Mascara’s own views, not the views of the US Government or VA

Indications for Growth Factors in Hematology-Oncology;

Guidelines for Chemotherapy Dosage Adjustment;

Drug Preparation and Administration

John Marshall, MD

Director, The Ruesch Center for the Cure of GI Cancers

Chief, Hematology and Oncology

Lombardi Comprehensive Cancer Center

Georgetown University Medical Center

Washington, DC

Anal Cancer; Esophageal Cancer

Dhaval Mehta, MD

Clinical Assistant Professor of Medicine

University of Pittsburgh School of Medicine

UPMC Hillman Cancer Center

Pittsburgh, Pennsylvania

Chronic Lymhocytic Leukemia

Cecilia Monge, MD

Gastrointestinal Malignancy Section

National Cancer Institute

National Institutes of Health

Bethesda, Maryland

Hepatocellular Carcinoma

Franco Muggia, MD

Professor of Medicine (Oncology)

Perlmutter Cancer Center

NYU Langone Medical Center

New York, New York

Vaginal Cancer

Ashok Nambiar, MD

Professor, Laboratory Medicine

Director, Transfusion Medicine

Director, Moffitt-Long & Mt. Zion Hospital Tissue Banks

UCSF Medical Center

University of California, San Francisco

San Francisco, California

Transfusion Therapy

Mariam Nawas, MD

Assistant Professor

Hematopoietic Cellular Therapy Program

Section of Hematology and Oncology

The University of Chicago Medical Center

Chicago, Illinois

Complications and Follow-Up After Hematopoietic Cell Transplantation

Cindy Neunert, MD, MSCS

Assistant Professor of Pediatrics

Section Head, Pediatric Hematology

Columbia University Medical Center

New York, New York

Idiopathic Thrombocytopenic Purpura

Enrico M. Novelli, MD, MS

Associate Professor of Medicine

UPMC and the University of Pittsburgh School of Medicine

Pittsburgh, Pennsylvania

Sickle Cell Disease: Acute Complications

Melanie S. Norris, PharmD

University of Pittsburgh School of Pharmacy

Pittsburgh, Pennsylvania

Kunle Odunsi, MD, PhD

Director of the University of Chicago Medicine Comprehensive Cancer Center

AbbVie Foundation Distinguished Service Professor of Obstetrics and Gynecology

Dean for Oncology, Biological Sciences Division

Chicago, Illinois

Ovarian Cancer

Naomi P. O’Grady, MD

Medical Director, Procedures, Vascular Access,

and Conscious Sedation Services

Department of Critical Care Medicine

National Institutes of Health

Bethesda, Maryland

Catheter-Related Bloodstream Infections: Management and Prevention

Karel Pacak, MD, PhD, DSc

Senior Investigator

Chief, Section on Medical Neuroendocrinology

Eunice Kennedy Shriver NICHD, National Institutes of Health

Bethesda, Maryland

Pheochromocytoma

Bhavisha Patel, MD

Staff Clinician

National Heart, Lung, and Blood Institute,

National Institutes of Health

Bethesda, Maryland

Aplastic Anemia

Khilna Patel, PharmD, BCOP, MBA

New York-Presbyterian Hospital | Columbia University Medical Center

New York, New York

Antineoplastic Drugs: Preventing and Managing Extravasation

Justin R. Price, MD

Assistant Professor in Hospice and Palliative care

University of Maryland Medical Center

Baltimore, Maryland

Cancer Pain: Assessment and Management

Sheila Prindiville, MD, MPH

Director, Coordinating Center for Clinical Trials

National Cancer Institute

Bethesda, Maryland

Cancer Screening; Genetics of Common Inherited Cancer Syndromes

Kanti Rai, MD

Professor, The Karches Center for Oncology Research, Feinstein Institutes for Medical Research

Joel Finkelstein Cancer Foundation Professor of Medicine and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

New Hyde Park, New York

Chronic Lymphocytic Leukemia

Margaret V. Ragni, MD, MPH

Professor of Medicine and Clinical Translational Science

Department of Medicine

Division of Hematology-Oncology

University of Pittsburgh School of Medicine

Director, Hemophilia Center of Western Pennsylvania

Pittsburgh, Pennsylvania

Hemophilia

Ramesh Rengan, MD, PhD, FASTRO

Professor and Chair

Department of Radiation Oncology

Fred Hutchinson Cancer Research Center

University of Washington

Seattle, Washington

Radiation Complications

Aldo Roccaro, MD, PhD

Dana Farber Cancer Institute

Harvard Medical School

Boston, Massachusetts

Multiple Myeloma

Griffin P. Rodgers, MD, MACP

Chief, Molecular and Clinical Hematology Branch

National Heart, Lung and Blood Institute

Director, National Institute of Diabetes,

Digestive and Kidney Diseases

National Institutes of Health

Bethesda, Maryland

Sickle Cell Disease: Acute Complication

Peter G. Rose, MD

Section Head Gynecologic Oncology

Cleveland Clinic Foundation

Tenured Professor of Surgery, Oncology and Reproductive Biology

Case Western Reserve University

Cleveland, Ohio

Cervical Cancer

Rafael Rosell, MD

IOR, Quirón-Dexeus

Rosell Molecular and Cellular Oncology Laboratory

Germans Trias i Pujol Research Institute and Hospital (IGTP)

Barcelona, Spain

Lung Cancer

Craig D. Seaman, MD, MS

Assistant Professor of Medicine

Division of Hematology-Oncology

Department of Medicine

University of Pittsburgh School of Medicine

Associate Director, Hemophilia Center of Western Pennsylvania

Pittsburgh, Pennsylvania

Hemophilia

Manish A. Shah, MD

Professor of Medicine

Director, Gastrointestinal Oncology

Weill Cornell Medical College of Cornell University

New York-Presbyterian

New York, New York

Gastric Cancer

Marie Scully, MD

Professor of Hematology

Department of Hematology

University College London Hospitals

London, United Kingdom

Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome

Britt Skogseid, MD, PhD

Professor of Endocrine Tumorbiology

Department of Endocrine Oncology

Uppsala University Hospital

Uppsala, Sweden

Neuroendocrine Tumors

Roy E. Smith, MD, MS

Professor of Medicine

Division of Hematology-Oncology

University of Pittsburgh School of Medicine

Pittsburgh, Pennsylvania

Venous Catheter-Related Thrombosis Iron Deficiency Anemia

Pol Specenier, MD, PhD

Department of Oncology

Antwerp University Hospital

Edegem, Belgium

Head and Neck Cancers

Jennifer M. Specht, MD

Associate Professor

Clinical Research Division

Fred Hutchinson Cancer Research Center

Associate Professor of Medicine

University of Washington School of Medicine

Seattle, Washington

Breast Cancer

David R. Spigel, MD

Chief Scientific Officer

Sarah Cannon Research Institute

Director, Lung Cancer Research Program

Principal Investigator

Tennessee Oncology

Nashville, Tennessee

Carcinoma of Unknown Primary

Jason Starr, DO

Department of Medicine

Mayo Clinic Hospital

Jacksonville, Florida

Colorectal Cancer

Maximilian Stahl, MD

Chief Hematology-Oncology Fellow

Memorial Sloan Kettering Cancer Center

Visiting Fellow, Rockefeller University

New York, New York

Hairy Cell Leukemia

J. Brian Szender MD, MPH

START Center for Cancer Care

San Antonio, Texas

Ovarian Cancer

Martin S. Tallman, MD

Chief of the Leukemia Service

Department of Medicine

Memorial Sloan Kettering Cancer Center

Professor of Medicine

Weill Cornell Medical College

New York, New York

Hairy Cell Leukemia; Acute Myeloid Leukemia

Ahmad A. Tarhini, MD, PhD

Director, Cutaneous Clinical and Translational Research

Leader, Cutaneous Neoadjuvant and Adjuvant Translational Science Program

Senior Member, Departments of Cutaneous Oncology and Immunology

H Lee Moffitt Cancer Center and Research Institute

Professor of Oncologic Sciences

University of South Florida Morsani College of Medicine

Tampa, Florida

Melanoma

Ayalew Tefferi, MD

Professor of Medicine

Division of Hematology

Mayo Clinic

Rochester, Minnesota

Myeloproliferative Neoplasms

Susanna Ulahannan, MD, MMed

Associate Director, Oklahoma TSET Phase 1 Program

NCI Early Stage Clinical Investigator

Assistant Professor of Medicine, Medical Oncology/Hematology

Stephenson Cancer Center at Oklahoma University Medicine

Oklahoma City, Oklahoma

Biliary: Gallbladder Cancer and Cholangiocarcinoma

Thomas S. Uldrick, MD, MS

Deputy Head, Global Oncology Program

Associate Professor

Vaccine and Infectious Disease Division

Clinical Research Division

Fred Hutchinson Cancer Research Center

Seattle, Washington

HIV-Related Malignancies

JB Vermorken, MD, PhD

Emeritus Professor of Oncology

Department of Medical Oncology

Antwerp University Hospital

Antwerp, Belgium

Head and Neck Cancers

Nicholas J. Vogelzang, MD

Clinical Professor of Medicine

Hematology-Oncology

University of Nevada, Las Vegas School of Medicine

Las Vegas, Nevada

Mesothelioma

Charles F. von Gunten, MD, PhD

Vice President, Medical Affairs

Hospice and Palliative Medicine for OhioHealth

Columbus, Ohio

Hospice Care and End-of-Life Issues

Daniel D. Von Hoff, MD, FACP

Physician in Chief, Distinguished Professor

Translational Genomics Research Institute

Professor of Medicine, Mayo Clinic

Chief Scientific Officer, Scottsdale Healthcare

Medical Director of Research and Scientific Medical Officer,

US Oncology Research

Senior Investigator

Clinical Professor of Medicine

Translational Genomics Research Institute

University of Arizona Cancer Center

Phoenix, Arizona

Pancreatic Cancer

Martin H. Voss, MD

Clinical Director

Genitourinary Oncology Service

Memorial Sloan Kettering Cancer Center

New York, New York

Renal Cell Cancer

Benjamin A. Weinberg, MD

Assistant Professor of Medicine, Division of Hematology and Oncology

Attending Physician, MedStar Georgetown University Hospital

Gastrointestinal Medical Oncologist

Lombardi Comprehensive Cancer Center

Georgetown University Medical Center

Georgetown, Wahington DC

Anal Cancer

Emily S. Weg, MD

Assistant Professor, Department of Radiation Oncology

University of Washington School of Medicine

Seattle, Washington

Radiation Complications

Brigitte Widemann, MD

Senior Investigator

Pediatric Oncology Branch

Center for Cancer research

National Cancer Institute, National Institutes of Health

Bethesda, Maryland

Sarcomas

Jacob E. Winschel, MS, PharmD

UPMC Presbyterian Hospital

Pittsburgh, Pennsylvania

Neal S. Young, MD

Chief, Hematology Branch

National Heart, Lung, and Blood Institute

National Institutes of Health

Bethesda, Maryland

Aplastic Anemia; Myelodysplastic Syndromes

Robert Yarchoan, MD

Chief. HIV and AIDS Malignancy Branch

Senior Investigator

Head, Viral Oncology Section

Director, Office of HIV and AIDS Malignancy

Center for Cancer research

National Cancer Institute, National Institutes of Health

Bethesda, Maryland

HIV-Related Malignancies

Rachel Yung, MD

Assistant Professor

Clinical Research Division, Fred Hutchinson Cancer Research Center

Asistant Professor of Medicine

University of Washington School of Medicine

Seattle, Washington

Breast Cancer

Wenhui Zhu, MD, PhD

Seidman Cancer Center

Southwest General Hospital

Middleburg Heights, Ohio

Prostate Cancer

Jeffrey I. Zwicker, MD

Associate Professor of Medicine

Division of Hematology-Oncology

Beth Israel Deaconess Medical Center, Harvard Medical School

Boston, Massachusetts

The Hypercoagulable State

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

Authors

Citation

Jump to a Section

Pop-up div Successfully Displayed